C3 BIOTECHNOLOGIES (BIO-PROPANE) LIMITED
Opportunity 76/100 (strong), bankability 75/100. Strong seller-intent signal (60/100, director aged 68). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: high (82/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-09-30 | 2024-09-30 |
|---|---|---|
| Average employees | 0 | 0 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 2 officers
- • 2 officers
- • 1 accounts
- • 2 officers
- • 1 accounts
- • 1 confirmation-statement
Corporate timeline (14 events)Click to expand
- 2026-07-06📄termination-director-company-with-name-termination-dateofficers · TM01
- 2026-07-06📄appoint-person-director-company-with-name-dateofficers · AP01
- 2026-07-02➕SMITH, Michael Hyde appointeddirector
- 2026-07-02➖SCRUTTON, Nigel, Professor resigneddirector
- 2026-06-19📄accounts-with-accounts-type-dormantaccounts · AA
- 2026-01-14📄change-person-director-company-with-change-dateofficers · CH01
- 2025-06-20📄accounts-with-accounts-type-dormantaccounts · AA
- 2023-11-15📄accounts-with-accounts-type-dormantaccounts · AA
- 2022-12-13📄accounts-with-accounts-type-dormantaccounts · AA
- 2022-04-06📄capital-allotment-sharescapital · SH01
- 2021-04-28📄change-account-reference-date-company-current-extendedaccounts · AA01
- 2021-04-08🏢Company incorporatedAs C3 BIOTECHNOLOGIES (BIO-PROPANE) LIMITED
- 2021-04-08➕SCRUTTON, Nigel, Professor appointeddirector
- 2021-04-08📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Founder age: Director aged approximately 68 — succession pressure is live.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primaryFounder aged 63+: Senior director is approximately 68. Approaching typical UK retirement age — succession thinking likely.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanGroup structure
C3 Biotechnologies Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
C3 Biotechnologies Limited Corporate entity | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 08/04/2021 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Professional services · LA postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ALPHA OMEGA LEGAL LIMITED→ 07887898 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| ASKAM PLANT LIMITED→ 09588824 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| BOWLINE MARINE ENGINEERING LTD→ 11687299 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| BUILT HERITAGE LTD→ 15746764 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| C & C HANKINSON LTD→ 15784791 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| C3 BIOTECHNOLOGIES (ACRYLICS) LIMITED→ 15251696 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| C3 BIOTECHNOLOGIES (HYPERSONICS) LIMITED→ 15401074 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| C3 BIOTECHNOLOGIES (MARITIME AND AEROSPACE) LIMITED→ 12795742 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| C3 SYSTEMS LTD→ 16456924 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| CADENCE CREATIVE LTD→ 10828132 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| CAINE PERFORMANCE LTD→ 13104244 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| CALABRIAN LIMITED→ 09365138 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 1 resigned)
Click a director name to see their full track record across all companies.